Government news, all in one place
Government news, all in one place
454 articles
Showing 241-270
Monday, 30 May 2022
Details of the VMD’s second Equine Anthelmintic Resistance Stakeholder Meeting and the next steps to developing a pan-industry equine group....
Wednesday, 18 May 2022
Details of seizure notice served following a parcel addressed to premises in County Fermanagh stopped at a Belfast depot....
Wednesday, 20 April 2022
Details of vacancy for a Facilities and Administrative Officer in the Corporate Services Team. ...
Monday, 04 April 2022
Details of a vacancy for an Administrative Officer, Operations Coordinator, in our residues section....
Monday, 04 April 2022
Announcing the launch of our new blog page with information to complement our regulatory guidance. ...
Tuesday, 29 March 2022
Details of a vacancy for an administration officer in our legislation section....
Wednesday, 23 March 2022
The VMD’s online services will be temporarily unavailable due to essential maintenance from Saturday 26 March to Sunday 27 March. ...
Monday, 14 March 2022
Details of a vacancy for a Senior Executive Officer in our legislation section. ...
Thursday, 10 March 2022
Recruitment details of a fixed term vacancy in our Legislation Team....
Monday, 07 March 2022
All statements relating to the temporary VMD enforcement policy have been withdrawn and are no longer in force....
Wednesday, 02 March 2022
Details of a vacancy for a Higher Scientific Officer in our Supply Team....
Wednesday, 16 February 2022
UK-New Zealand Regulatory Cooperation: Guidance on Veterinary Drug Simultaneous Reviews published....
Tuesday, 08 February 2022
Details of a recruitment for a Pharmacovigilance Assessor....
Tuesday, 01 February 2022
Details of a recruitment for the Head of Finance team....
Friday, 28 January 2022
Details of the implementation of EU Regulation 2019/6 and EU Regulation 2019/4 in Northern Ireland....
Wednesday, 26 January 2022
Details of vacancies for 2 Pharmaceutical Assessors in the Pharmaceuticals Quality Team....
Monday, 24 January 2022
The VMD’s online services are temporarily unavailable Monday 24 January due to emergency electrical works. ...
Wednesday, 12 January 2022
Details of the VMD Equine Anthelmintic Resistance Stakeholder Workshop....
Thursday, 06 January 2022
Details of a vacancy for a Pharmaceutical Assessor in the Quality Team....
Thursday, 06 January 2022
Details of a vacancy for an Executive Officer within the veterinary medicinal products Applications Management Team....
Thursday, 06 January 2022
Details of a vacancy for a Senior Scientific Officer in a specialist team within the Pharmaceuticals Section....
Wednesday, 05 January 2022
Details of the European Commission Implementing Decision to withdraw, by 26 June 2022, the MAs of veterinary medicines containing Zinc Oxide....
Tuesday, 21 December 2021
Details of a vacancy for an Administrative Officer in the International Office based in Addlestone, Surrey....
Tuesday, 21 December 2021
Details of a vacancy for the Head of the Pharmaceutical Quality Team....
Wednesday, 15 December 2021
Details of a VMD Veterinary Dispensary Manager course in May 2022...
Friday, 10 December 2021
Details of the joint VMD and VPC open information event....
Monday, 29 November 2021
Details of an online training course for veterinary Wholesale Qualified Persons (WQPs)....
Tuesday, 16 November 2021
Marketing Authorisation Holders (MAHs) have informed the VMD of supply problems with the following lactating cow intramammary antibiotics....
Tuesday, 26 October 2021
Applications are invited for new members to the VPC....
Tuesday, 26 October 2021
Details of a recruitment for a Good Manufacturing Practice Inspector....
Prime Minister's Office, 10 Downing Street PM call with the President of the UAE: 28 February 2026
Prime Minister's Office, 10 Downing Street PM call with the Amir of Qatar: 28 February 2026
Prime Minister's Office, 10 Downing Street PM statement on Iran: 28 February 2026
Prime Minister's Office, 10 Downing Street Joint E3 Leaders’ Statement on Iran: 28 February 2026
Medicines and Healthcare products Regulatory Agency MHRA statement on Pathways clinical trial